Translational Research Center in Lung Cancer Disparities (TRACER) Project 2
Launched by VIRGINIA COMMONWEALTH UNIVERSITY · Aug 3, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The TRACER Project 2 is a clinical trial that aims to understand how smoking behaviors and stress responses differ between African American and white male smokers. Researchers want to learn more about these differences to help develop better support and treatment options for smokers from various backgrounds. The study is currently recruiting participants who are men aged 18 to 75, smoke at least 5 to 10 cigarettes a day, and identify as either African American or white.
If you qualify and decide to participate, you will be involved in discussions and assessments that focus on your smoking habits and how stress affects you. However, this study is not for everyone; individuals with serious cognitive disorders, a history of lung cancer, recent substance abuse issues, or those currently enrolled in smoking cessation programs cannot participate. This trial offers a chance to contribute to important research that could improve smoking cessation strategies for different racial groups.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • African American and white males
- • Between the ages of 18-75 years old
- • Smoke at least 5 to 10 cigarettes per day
- Exclusion Criteria:
- • Smokers who have a serious cognitive disorder
- • Have a personal history of lung cancer
- • Personal history of usage of illicit drug and alcohol abuse
- • Enrollment in a smoking cessation treatment program during the past 6 months
- • Current use of a nicotine replacement therapy
- • Have any positive responses on the Mini International Neuropsychiatric Interview (MINI) screener
About Virginia Commonwealth University
Virginia Commonwealth University (VCU) is a prominent academic institution and research leader located in Richmond, Virginia. Renowned for its commitment to advancing healthcare through innovative research and education, VCU plays a pivotal role in clinical trials aimed at improving patient outcomes and understanding complex health issues. The university boasts a collaborative environment, leveraging its diverse faculty expertise and state-of-the-art facilities to conduct rigorous clinical research across various medical disciplines. VCU's dedication to ethical research practices and community engagement ensures that its clinical trials are designed to address critical health challenges while prioritizing participant safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charleston, South Carolina, United States
Richmond, Virginia, United States
Los Angeles, California, United States
Patients applied
Trial Officials
Robert Winn, MD
Principal Investigator
Virginia Commonwealth University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials